BLRX
BioLineRx Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.49
−1.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.88x
- Price / sales
- 10.14x
- Price / cash flow
- -1.48x
Enterprise value
- Enterprise value
- $9.8M
- EV / sales
- 8.22x
- EV / EBITDA
- -43.47x
- EV / EBIT
- -0.94x
- Market cap
- $12.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026